- Explained: Why monsoon is expected to pick up in July
- New worry in J&K: Officers say militancy entering a ‘secretive, dangerous’ phase
- SpiceJet snags: One lands in Pakistan, another has a windshield crack
- Cell therapy cancer centre takes shape in Bengaluru, trials are on
- Rishi Sunak, Sajid Javid resign from Boris Johnson's cabinet: The Chris Pincher scandal, explained
- Funding winter sets in for Indian startups, staff out in the cold: Over 12K laid off
- Unity and diversity: Our obsession with diversity misses the point
- Why India's bowlers failed to defend 378 at Edgbaston
- Madhavan shares AR Rahman's reaction to Rocketry at Cannes: 'Unforgettable moments of my life'
Gilead Sciences
GILEAD SCIENCES NEWS
Gilead's COVID-19 drug helps boost 2nd-quarter results as HIV sales dip
July 30, 2021 9:35 am
Sales of HIV medicines, which have stalled during the coronavirus pandemic, fell 2 per cent to $3.9 billion.
Gilead announces steps to expand availability of remdesivir in India
April 27, 2021 10:11 am
In addition to providing support to its licensees to expand their local manufacturing capacity, Gilead will also donate at least 450,000 vials of Veklury (remdesivir) to help address the immediate needs of Indian patients, the company said.
Explained: Why WHO vs Gilead on Remdesivir matters
October 19, 2020 12:53 pm
What do the WHO Solidarity trial data say about the effectiveness of remdesivir? What is the drugmaker’s retort, and what does this mean for the treatment line for Covid-19?
Gilead Sciences announces approval of Remdesivir in India for patients with severe Covid-19
June 04, 2020 12:25 am
A statement issued on Wednesday stated that the regulatory approval is supported by clinical data from the US National Institute of Allergy and Infectious Diseases’
US pharma giant Gilead Sciences seeks marketing authorisation from India for remdesivir
May 30, 2020 11:17 am
Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said. The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) to treat hospitalised coronavirus patients.
Gilead says remdesivir shows improvement in COVID-19 patients when used early
April 29, 2020 10:11 pm
Interest in Gilead’s drug has been high as there are currently no approved treatments or preventive vaccines for COVID-19, and doctors are desperate for anything that might alter the course of the disease that attacks the lungs and can shut down other organs in extremely severe cases.
Gilead to license hepatitis C drug to Indian firms
April 09, 2014 1:39 am
Gilead is under pressure to address the high cost of its breakthrough pill, which is the first of a new wave of drugs that have been shown to raise cure rates and cut treatment duration without the side effects.
CCI rules out case against US-based pharmaceutical,Gilead Sciences
March 12, 2013 2:53 pm
Fair trade regulator Competition Commission of India has rejected a complaint against Gilead Sciences Inc.
'MNCs ganged-up against Indian pharma'
March 07, 2011 3:08 pm
Global success in generics by Indian companies has created fear among MNCs.
Best of Express
CitiesUddhav’s fresh salvo at Shinde: Auto driver whose brakes failed
TechnologyTwitter takes Centre to court over some orders for takedown of content
EntertainmentKoffee Koffee hota hai: What is it about Karan Johar’s brew that has audiences asking for one more cuppa?
EntertainmentAs the era of superstardom ends, how Ranveer Singh emerged as the modern Indian hero
TrendingThis heartwarming thread on Keanu Reeves is winning the internet
TrendingWatch: Fan makes cricketer Dinesh Karthik’s portrait with Rubik's Cubes
SportsThe secret of in-form Bairstow's success: Staying still, getting balance right and a relaxed mind 
SportsJoe Root - the real ringmaster of Birmingham
OpinionMaking sense of Assam floods
Why did Rishi Sunak, Sajid Javid resign from Boris Johnson's cabinet?
LifestyleDoes egg yolk have fat and cholesterol? Find out here- TechnologyTwitter takes Centre to court over content takedown orders
Jul 06: Latest News
MSU syndicate rejects student’s appeal to reconsider rustication
I’m in the semi-finals but still have nappies to change: Tatjana Maria
Footwear shop owner’s son, daughters of plumber, labourer among Mohali toppers
Gujarat has progressed from tanker raj to Nal se Jal: Agriculture Minister
We will review why batters are failing in 3rd innings of Test matches: Rahul Dravid
ABIL group chairman Avinash Bhosale’s ED custody extended till July 11
Moosewala murder: Mansa police get remand of four accused till July 13
Gujarat: Students escape as part of Dahod school building collapses on holiday
India register second draw in Women’s Hockey WC, held 1-1 by China
Explained: The three new ‘exotic’ sub-atomic particles discovered at CERN